Serif Biomedicines
Pioneering Modified DNA therapeutics
CORE INFO
Serif Biomedicines is a biotechnology company focused on developing Modified DNA therapeutics to address challenges in DNA therapies, such as immunogenicity and inefficient nuclear access, without altering the cell's genome. Their innovative approach targets rare diseases and immune programming, appealing to healthcare and biotechnology sectors.
- Serif Biomedicines emerged from five years of platform development with an initial commitment of $50 million from Flagship Pioneering.flagshippioneering.com
- The company's Modified DNA platform is protected by more than 20 patent families, including issued U.S. patents.flagshippioneering.com
WHY WE WOULD WORK AT SERIF BIOMEDICINES
Pioneering Technology
Join a team at the forefront of biotechnology, developing Modified DNA therapeutics that combine mRNA and gene therapy to tackle rare diseases.
Meaningful Impact
Contribute to groundbreaking solutions that aim to improve patient outcomes and address significant healthcare challenges.
Innovative Learning Environment
Work alongside experts in nucleic acid chemistry and synthetic biology, fostering continuous learning and professional growth.
Strong Financial Backing
Benefit from a solid foundation with $50 million in initial funding from Flagship Pioneering, ensuring resources for ambitious projects.
Cutting-Edge Research
Engage in advanced research protected by over 20 patent families, positioning you at the cutting edge of genetic medicine.
Collaborative Culture
Be part of a dynamic team that values collaboration and innovation, driving collective success in a supportive environment.
MARKET AND TRACTION
TOTAL ADDRESSABLE MARKET
KEY METRICS
✦ KEY METRICCOMPETITIVE ADVANTAGE
NOTABLE ACHIEVEMENTS
MARKET POSITION
PRODUCT AND TECH
Modified DNA Therapeutics
Serif Biomedicines is pioneering Modified DNA as a new class of medicines, combining elements of mRNA and gene therapy to create therapeutics that are programmable, scalable, durable, and redosable.
Nucleic Acid Chemistry
The company integrates advanced nucleic acid chemistry into its platform to enhance the efficacy and safety of its Modified DNA therapeutics, addressing traditional challenges in DNA therapies.
Synthetic Biology Integration
Serif employs synthetic biology techniques to design and optimize its Modified DNA constructs, enabling precise control over therapeutic outcomes and improved delivery mechanisms.
Delivery Science Innovations
Innovative delivery science is a core component of Serif's approach, focusing on overcoming barriers to nuclear access and ensuring effective therapeutic delivery without altering the cell's genome.
Artificial Intelligence Applications
Serif utilizes artificial intelligence to streamline drug discovery processes, enhancing the identification and development of therapeutics targeting rare diseases and immune programming.